Sun Pharmaceutical Industries Ltd. 524715 shares slid 1.14% to 1,779.30 Indian rupees Wednesday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX Index ...

IPM sales grew by 6.1% year on year during the month ... marking the highest in this group. Sun Pharmaceuticals Industries ...

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Dilip Shanghvi's journey from the beginning with just Rs 2,000 highlights the importance of resilience, adaptability, and ...

Wegovy and Ozempic drove Novo Nordisk to record bumper sales since the launch ... at least five to six players are working on ...

Brand-heavy companies such as Mankind Pharma, Sun Pharma, Torrent Pharmaceuticals and Eris Lifesciences are expected to ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Indian drugmaker Alembic Pharmaceuticals reported a smaller-than-expected rise in second-quarter profit on Thursday, hurt by a slowdown in the U.S. market amid pricing pressure.

How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

India's J B Chemicals & Pharmaceuticals reported a rise in second-quarter profit on Wednesday, helped by higher domestic demand for its gastrointestinal and cardiovascular drugs. The drugmaker's ...